2:38newsJanuary 25, 2022Pfizer starts trials for omicron-specific boosterThe pharmaceutical company announced the beginning of its trials, with more than 1,400 patients set to receive one or more doses of the variant-based vaccine.Up Next in newsCOVID cases drop in some parts of the country, spike in othersJanuary 24, 2022Watch moving moment paralyzed shooting victim walks across stage to receive diploma May 18, 2023Woman alleges strangers placed bucket on her head while shoppingApril 13, 2023